Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

MBX Biosciences (MBX) Other Gross PP&E Adjustments (2023 - 2026)

MBX Biosciences has reported Other Gross PP&E Adjustments over the past 4 years, most recently at $3.4 million for Q1 2026.

  • Quarterly results put Other Gross PP&E Adjustments at $3.4 million for Q1 2026, up 78.09% from a year ago — trailing twelve months through Mar 2026 was $3.4 million (up 78.09% YoY), and the annual figure for FY2025 was $1.5 million, up 174.78%.
  • Other Gross PP&E Adjustments reached $3.4 million in Q1 2026 per MBX's latest filing, up from $1.5 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $3.4 million in Q1 2026 and bottomed at $110000.0 in Q4 2023.
  • Median Other Gross PP&E Adjustments over the past 4 years was $1.6 million (2025), compared with a mean of $1.6 million.
  • The largest annual shift saw Other Gross PP&E Adjustments soared 408.18% in 2024 before it surged 67.52% in 2025.
  • Over 4 years, Other Gross PP&E Adjustments stood at $110000.0 in 2023, then skyrocketed by 408.18% to $559000.0 in 2024, then surged by 174.78% to $1.5 million in 2025, then soared by 122.27% to $3.4 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for MBX at $3.4 million in Q1 2026, $1.5 million in Q4 2025, and $2.1 million in Q3 2025.